Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
That combo of AI and genetic screening is a game-changer for IVF, seriously pushing the needle on success rates. It's exciting to see how this tech is directly impacting patient outcomes.
That's a straightforward formula for success in the market. Alpha definitely can consistently deliver on those points, the share price will likely follow suit